A. Rapkin

Publications133
h-index36
Citations4,895
Highly Influential Citations201
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • E. Mayer
  • 792 Publications • 42,120 Citations
  • E. Freeman
  • 258 Publications • 14,593 Citations
  • S. Bergeron
  • 190 Publications • 6,194 Citations
  • T. Bäckström
  • 302 Publications • 11,288 Citations
  • Publications
  • Influence
Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus
TLDR
An international multidisciplinary group of experts met at a face-to-face consensus meeting to review current definitions and diagnostic criteria for PMD to provide a unified approach for the diagnostic criteria, their quantification and guidelines on clinical trial design.
Efficacy of a New Low-Dose Oral Contraceptive With Drospirenone in Premenstrual Dysphoric Disorder
TLDR
A 24/4 regimen of drospirenone 3 mg and ethinyl estradiol 20 &mgr;g improves symptoms associated with premenstrual dysphoric disorder.
Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness
  • A. Rapkin, S. Winer
  • Psychology, Medicine
    Expert review of pharmacoeconomics & outcomes…
  • 1 April 2009
TLDR
This review will focus on the epidemiology, diagnosis, treatment outcomes, quality of life and burden of illness for premenstrual disorders.
Progesterone Metabolite Allopregnanolone in Women With Premenstrual Syndrome
A review of treatment of premenstrual syndrome & premenstrual dysphoric disorder
  • A. Rapkin
  • Medicine
    Psychoneuroendocrinology
  • 1 August 2003
Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies
TLDR
An international multidisciplinary group of experts evaluated the current definitions and diagnostic criteria of PMS and premenstrual dysphoric disorder and proposed guidelines for quantification of criteria to facilitate diagnostic uniformity in the field as well as adequate treatment modalities when warranted.
Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder.
TLDR
The results of this study show a consistent trend in the reduction of symptoms that suggested a beneficial effect of DRSP/EE for the treatment of PMDD, despite limitations of the study design.
ISPMD consensus on the management of premenstrual disorders
TLDR
The second consensus meeting of the International Society for Premenstrual Disorders took place in London during March 2011 and agreed that careful diagnosis based on the recommendations and classification derived from the first ISPMD consensus conference is essential and should underlie the appropriate management strategy.
An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome.
Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder
TLDR
Brain imaging studies have begun to shed light on the complex brain circuitry underlying affect and behaviour and may help to explicate the intricate neurophysiological foundation of the syndrome.
...
1
2
3
4
5
...